Impact Factor
3.26
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.63
406 total citations
h5-index
24
h5 depth signal
Cited share
66.9%
105 of 157
Total citations
406
Citation footprint
Metric signal
3.30
External metric anchor
Self-citation
2.5%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
233
United Kingdom
129
Canada
77
Australia
75
Netherlands
37
Citing Fields of Research
Nutrition & Dietetics
492
Diabetes
160
Psychiatry
76
Endocrinology & Metabolism
42
Abdominal Surgery
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
897
Articles tracked across the journal lifetime
Indexed publication set
157
105 cited publications
Last 12 months
71
6.5 publications/month
Open access share
47.9%
34 OA publications in the last year
Leading citing country
United States
233 citing publications
Leading citing field
Nutrition & Dietetics
492 citing publications
Latest tracked publication
8 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Feb. 2014
v4n1, Feb. 2014- ; selected citations only before this date
Research Focus & Classification
Indexed Subjects
Nutrition & Dietetics
Diabetes
Issuing & Sponsoring Bodies
Contributor
International Association for the Study of Obesity
Broad Categories
Metabolism
Nutrition & Dietetics
MeSH Descriptors
Obesity
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/cob.70116
Open DOI
Weight‐Loss Outcomes After Sleeve Gastrectomy Versus Tirzepatide in a Minority Cohort With Severe Obesity: Results From a Propensity Score Matched Cohort
While GLP‐1 and GIP receptor agonists like semaglutide and tirzepatide have revolutionized pharmacologic obesity treatment, metabolic and bariatric surgery (MBS) continues to demonstrate superior weight loss and cost‐effectiveness. Curre...
02
DOI 10.1111/cob.70060
Open DOI
Issue Information
03
DOI 10.1111/cob.70115
Open DOI
Lipoedema and Obesity Misclassification: A Phenotype Based Approach to Cardiometabolic Risk Beyond Body Mass Index
Lipoedema is a painful adipose tissue disorder marked by disproportionate limb fat and often misclassified as generalized obesity or lymphoedema. This review examines its metabolic phenotype and implications for cardiometabolic assessmen...
04
05
DOI 10.1111/cob.70112
Open DOI
Weight Reduction Heterogenicity and Mediators of GLP ‐ 1RAs and Dual Agonists for Individuals With Obesity: A Meta‐Analysis
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and dual agonists have become pivotal options for obesity, but marked weight loss heterogeneity remains poorly understood. This meta‐regression analysis aimed to identify factors influ...
06
DOI 10.1111/cob.70113
Open DOI
Effectiveness of Obesity Management Education for Healthcare Professionals: A Rapid Review and Meta‐Analysis
Healthcare professionals (HCPs) play a critical role in obesity management, yet many report inadequate training, low confidence and stigma‐related attitudes. While education programmes have been developed to address these issues, evidenc...
07
DOI 10.1111/cob.70109
Open DOI
IMPROVE 2025: The 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence
An international cohort of 161 clinicians and researchers from 19 countries attended the 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE) in Prague, Czech Republic, on 2–4 July 2025. The aims of the meeti...
08
DOI 10.1111/cob.70110
Open DOI
Effect of Bariatric Surgery on Improvement of Retinal Microvasculature in Patients With Obesity: A Systematic Review and Meta‐Analysis
Obesity is associated with adverse retinal microvascular changes, including narrower central retinal arteriolar equivalent (CRAE), wider central retinal venular equivalent (CRVE) and lower arteriovenous ratio (AVR). Although bariatric su...
09
DOI 10.1111/cob.70111
Open DOI
Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Head‐to‐Head Studies
This systematic review and meta‐analysis aimed to compare the efficacy and safety of tirzepatide versus semaglutide for weight reduction in adults with overweight or obesity. We included randomised controlled trials and observational stu...
10
Bibliographical & Catalog Notes
Also issued online.